Eli Lilly and Company(LLY) - Stock detail

Eli Lilly and Company

US
LLY
Eli Lilly and Company(Listing date: 07/09/1970)

Eli Lilly and Company was incorporated in Indiana in 1901, with its predecessor being a pharmaceutical manufacturing enterprise founded by Colonel Eli Lilly in Indianapolis, Indiana in 1876. The company develops, manufactures and markets important pharmaceutical products. Its mission is to combine "Caring" and "Discovery" to create better lives for people around the world.

AI Rating

Rating methodology
Latest close (chg%)1160.95+2.16%
Buy price
975.00
Target price975.00
Sell price1130.00
P/E TTM36.01
P/E91.43
Confidence80%
Risk score65/100
AI Summary
Committee recommends full sell due to extreme valuation (forward P/E 91.43), technical exhaustion (RSI 70.06, price at upper Bollinger Band), high debt leverage (73.24% Debt-to-Asset), and emerging competitive threats creating asymmetric downside risk. Profit-taking is prioritized over holding at bubble-level pricing.

Alpha Score

0-10
  • Trend（Score 4/10）

    Eli Lilly and Company (LLY) exhibits a strong but overextended bullish technical picture with powerful momentum, high volume confirmation, and clear uptrend supported by all major moving averages, though overbought conditions suggest elevated risk of near-term consolidation or pullback.

  • Valuation（Score 2/10）

    Valuation metrics reflect a market pricing in phenomenal growth, resulting in premium multiples. Based on traditional absolute valuation metrics (P/E, P/B, P/S), Eli Lilly's stock appears significantly overvalued with minimal margin of safety at current levels.

  • Financial strength（Score 5/10）
    Financial health shows a mixed picture with adequate short-term liquidity but high financial leverage, with a debt-to-asset ratio of 73.24% indicating significant financial risk.
  • Profitability（Score 9/10）
    Eli Lilly is demonstrating exceptionally strong and accelerating profitability, with explosive revenue and profit growth, significant margin expansion, and extraordinarily high returns on capital.
  • Sentiment（Score 0/10）
    No summary available
Latest price
$1160.95+2.16%
Market cap1.09T
P/E TTM36.01
P/E91.43
Volume2.76M
Turnover3.17B